567 followers
RT @FrontImmunol: New Research: Efficacy and safety of BVAC-C in HPV type 16- or 18–positive cervical carcinoma who failed 1st platinum-bas…
RT @FrontImmunol: New Research: Efficacy and safety of BVAC-C in HPV type 16- or 18–positive cervical carcinoma who failed 1st platinum-bas…
New Research: Efficacy and safety of BVAC-C in HPV type 16- or 18–positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study: Background BVAC-C, a B cell– and monocyte-based immunotherapeutic vaccine… https://t.co/peNwo7Dd
Efficacy and safety of BVAC-C in HPV type 16- or 18–positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study https://t.co/FHIiyCCmdb #FrontImmunol